Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Randomized Controlled Trials

Table 3

Study treatment doses.

	Patients, (%)
Plasma dose ()
10 mL/kg	11 (55)
12 mL/kg	4 (20)
15 mL/kg	5 (25)
4F-PCC dose ()
25 IU/kg	11 (50)
35 IU/kg	4 (18)
50 IU/kg	7 (32)

4F-PCC, 4-factor prothrombin complex concentrate.